Experienced in Epididymitis

Dr. Alan W. Skolnick

Urology
915 Gessner Rd, Suite 720, 
Houston, TX 
Experienced in Epididymitis
915 Gessner Rd, Suite 720, 
Houston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Alan Skolnick is an Urologist in Houston, Texas. Dr. Skolnick is rated as an Experienced provider by MediFind in the treatment of Epididymitis. His top areas of expertise are Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Enlarged Prostate (BPH), and Acute Cystitis.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Urology
Licenses
Urology in TX
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

915 Gessner Rd, Suite 720, Houston, TX 77024

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 2 Randomized, Double-blind, Placebo-controlled Trial and Open Label Extension to Evaluate the Safety and Efficacy of Deupirfenidone (LYT-100) in Post-acute COVID-19 Respiratory Disease
A Phase 2 Randomized, Double-blind, Placebo-controlled Trial and Open Label Extension to Evaluate the Safety and Efficacy of Deupirfenidone (LYT-100) in Post-acute COVID-19 Respiratory Disease
Enrollment Status: Terminated
Publish Date: February 14, 2024
Intervention Type: Drug, Other
Study Drug: Deupirfenidone
Study Phase: Phase 2
A Randomized Double-Blind, Sponsor-Open, Double-Dummy, Proof of Concept Phase 2 Study to Evaluate the Efficacy and Safety of TAK-951 Versus Ondansetron in the Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Subjects
A Randomized Double-Blind, Sponsor-Open, Double-Dummy, Proof of Concept Phase 2 Study to Evaluate the Efficacy and Safety of TAK-951 Versus Ondansetron in the Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Subjects
Enrollment Status: Completed
Publish Date: April 21, 2023
Intervention Type: Drug
Study Phase: Phase 2
Phase 3, Randomized, Placebo-Controlled, Efficacy and Safety Study of VERU-111 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS).
Phase 3, Randomized, Placebo-Controlled, Efficacy and Safety Study of VERU-111 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS).
Enrollment Status: Completed
Publish Date: April 18, 2023
Intervention Type: Drug
Study Drug: VERU-111
Study Phase: Phase 3
A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With Standard of Care Versus Standard of Care in Subjects Hospitalized With COVID-19
A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With Standard of Care Versus Standard of Care in Subjects Hospitalized With COVID-19
Enrollment Status: Completed
Publish Date: January 18, 2023
Intervention Type: Drug, Other
Study Drug: Abivertinib
Study Phase: Phase 2
View 3 Less Clinical Trials

3 Total Publications

Evaluation of the potential of Rejuveinix plus dexamethasone against sepsis.
Evaluation of the potential of Rejuveinix plus dexamethasone against sepsis.
Journal: Future microbiology
Published: September 02, 2022
Similar Doctors
Advanced in Epididymitis
Dr. Antoine A. Makhlouf
Urology
Advanced in Epididymitis
Dr. Antoine A. Makhlouf
Urology

Hillcroft Medical Clinic Assoc

1429 Hwy 6, 
Sugar Land, TX 
 (13.2 miles away)
713-781-4600
Languages Spoken:
English, Arabic, French, Spanish
See accepted insurances

Antoine Makhlouf is an Urologist in Sugar Land, Texas. Dr. Makhlouf is rated as a Distinguished provider by MediFind in the treatment of Epididymitis. His top areas of expertise are Perirenal Abscess, Carbuncle, Boils, Lithotripsy, and Ureteroscopy.

Advanced in Epididymitis
Dr. Kumaran Sathyamoorthy
Urology
Advanced in Epididymitis
Dr. Kumaran Sathyamoorthy
Urology
10425 Huffmeister Rd, Suite 210, 
Houston, TX 
 (11.3 miles away)
281-890-9111
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kumaran Sathyamoorthy is an Urologist in Houston, Texas. Dr. Sathyamoorthy is rated as a Distinguished provider by MediFind in the treatment of Epididymitis. His top areas of expertise are Hydronephrosis, Obstructive Uropathy, Urinary Tract Infection in Children, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Sathyamoorthy is currently accepting new patients.

Advanced in Epididymitis
Dr. Cordell O. Nwokeji
Urology | General Surgery
Advanced in Epididymitis
Dr. Cordell O. Nwokeji
Urology | General Surgery

Urology Specialists Of Kingwood, PLLC

22999 Hwy 59 N, Kingwood Medical Center, 
Kingwood, TX 
 (25.5 miles away)
281-348-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Cordell Nwokeji is an Urologist and a General Surgeon in Kingwood, Texas. Dr. Nwokeji is rated as a Distinguished provider by MediFind in the treatment of Epididymitis. His top areas of expertise are Obstructive Uropathy, Hydronephrosis, Urinary Tract Infection in Children, Prostatectomy, and Ureteroscopy. Dr. Nwokeji is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Skolnick's expertise for a condition
ConditionClose
        View All 17 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile